|
US3539794A
(en)
|
1967-09-12 |
1970-11-10 |
American Cyanamid Co |
Self-contained chemiluminescent lighting device
|
|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3630200A
(en)
|
1969-06-09 |
1971-12-28 |
Alza Corp |
Ocular insert
|
|
US3710795A
(en)
|
1970-09-29 |
1973-01-16 |
Alza Corp |
Drug-delivery device with stretched, rate-controlling membrane
|
|
US3847770A
(en)
|
1972-04-10 |
1974-11-12 |
Continental Can Co |
Photopolymerizable compositions prepared from beta hydroxy esters and polyitaconates
|
|
GB1429184A
(en)
|
1972-04-20 |
1976-03-24 |
Allen & Hanburys Ltd |
Physically anti-inflammatory steroids for use in aerosols
|
|
US4044126A
(en)
|
1972-04-20 |
1977-08-23 |
Allen & Hanburys Limited |
Steroidal aerosol compositions and process for the preparation thereof
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
US4002531A
(en)
|
1976-01-22 |
1977-01-11 |
Pierce Chemical Company |
Modifying enzymes with polyethylene glycol and product produced thereby
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
LU76148A1
(cg-RX-API-DMAC7.html)
|
1976-11-08 |
1978-07-10 |
|
|
|
SU787035A1
(ru)
|
1978-01-11 |
1980-12-15 |
Всесоюзный научно-исследовательский и испытательный институт медицинской техники |
Устройство дл введени лекарственных препаратов
|
|
US4202314A
(en)
|
1978-11-20 |
1980-05-13 |
Busygin Valery P |
Device for injection of medicinal preparations
|
|
JPS57128634A
(en)
|
1981-02-03 |
1982-08-10 |
Eisai Co Ltd |
Elastase-containing compound increasing absorption
|
|
DE3278101D1
(en)
|
1981-08-10 |
1988-03-17 |
Duphar Int Res |
Automatic injection syringe
|
|
US4645668A
(en)
*
|
1983-08-04 |
1987-02-24 |
Biospecifics, Nv |
Method for the prevention and treatment of scars with enzymes
|
|
US4952496A
(en)
|
1984-03-30 |
1990-08-28 |
Associated Universities, Inc. |
Cloning and expression of the gene for bacteriophage T7 RNA polymerase
|
|
US4769027A
(en)
|
1984-08-15 |
1988-09-06 |
Burroughs Wellcome Co. |
Delivery system
|
|
US4687610A
(en)
|
1986-04-30 |
1987-08-18 |
E. I. Du Pont De Neumours And Company |
Low crystallinity polyester yarn produced at ultra high spinning speeds
|
|
SE457417B
(sv)
|
1987-04-14 |
1988-12-27 |
Astra Meditec Ab |
Automatisk tvaakammarspruta, foerfarande foer blandning och injicering med sprutan samt ampull foer tvaakammarspruta
|
|
GB2205643B
(en)
|
1987-05-08 |
1991-03-13 |
Farmos Group Limited |
Type iii collagen degradation assay
|
|
US5052558A
(en)
|
1987-12-23 |
1991-10-01 |
Entravision, Inc. |
Packaged pharmaceutical product
|
|
US5033252A
(en)
|
1987-12-23 |
1991-07-23 |
Entravision, Inc. |
Method of packaging and sterilizing a pharmaceutical product
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
IT1229203B
(it)
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5324844A
(en)
|
1989-04-19 |
1994-06-28 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
|
DE3921528A1
(de)
|
1989-06-30 |
1991-01-10 |
Draegerwerk Ag |
Messzelle fuer den elektrochemischen gasnachweis
|
|
US5120548A
(en)
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
US5051449A
(en)
|
1991-02-27 |
1991-09-24 |
Kligman Albert M |
Treatment of cellulite with retinoids
|
|
GB9105893D0
(en)
|
1991-03-20 |
1991-05-08 |
Orion Yhtymae Oy |
Bone resorption assay based on a peptide liberated during collagen degradation
|
|
US5580578A
(en)
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
US5171081A
(en)
|
1992-05-29 |
1992-12-15 |
Pita Joe W |
Chemiluminescent reactive vessel
|
|
CA2098777A1
(en)
|
1992-06-19 |
1993-12-20 |
Yukio Fujisawa |
Production of human cathepsin and its use
|
|
JPH0775573A
(ja)
|
1992-06-19 |
1995-03-20 |
Takeda Chem Ind Ltd |
ヒトカテプシンの製造法および該酵素含有製剤
|
|
US5323907A
(en)
|
1992-06-23 |
1994-06-28 |
Multi-Comp, Inc. |
Child resistant package assembly for dispensing pharmaceutical medications
|
|
JPH06192124A
(ja)
|
1992-12-25 |
1994-07-12 |
Toray Ind Inc |
血液細胞増加剤
|
|
US5353961A
(en)
|
1993-01-15 |
1994-10-11 |
Reseal International Limited Partnership |
Dual chamber dispenser
|
|
US5591767A
(en)
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
WO1994028024A1
(en)
|
1993-06-01 |
1994-12-08 |
Enzon, Inc. |
Carbohydrate-modified polymer conjugates with erythropoietic activity
|
|
US5354566A
(en)
|
1993-06-02 |
1994-10-11 |
Kraft General Foods, Inc. |
Preparation of yeast-leavened dough crusts
|
|
GB9319103D0
(en)
|
1993-09-15 |
1993-11-03 |
Unilever Plc |
Skin care method & composition
|
|
US5395326A
(en)
|
1993-10-20 |
1995-03-07 |
Habley Medical Technology Corporation |
Pharmaceutical storage and mixing syringe having high pressure assisted discharge
|
|
US5643575A
(en)
|
1993-10-27 |
1997-07-01 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5919455A
(en)
|
1993-10-27 |
1999-07-06 |
Enzon, Inc. |
Non-antigenic branched polymer conjugates
|
|
US5446090A
(en)
|
1993-11-12 |
1995-08-29 |
Shearwater Polymers, Inc. |
Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
|
|
DK0750672T3
(da)
|
1994-03-17 |
2002-03-18 |
Max Delbrueck Centrum |
DNA-sekvenser for matrix-metalproteaser, deres tilvejebringelse og anvendelse
|
|
EE9600121A
(et)
|
1994-03-31 |
1997-04-15 |
Amgen Inc. |
Megakarüotsüütide kasvu ja diferentseerumist stimuleerivad kompositsioonid ja meetodid
|
|
US5795569A
(en)
|
1994-03-31 |
1998-08-18 |
Amgen Inc. |
Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
|
|
IT1270594B
(it)
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
US6093563A
(en)
|
1994-07-08 |
2000-07-25 |
Ibex Technologies R And D, Inc. |
Chondroitin lyase enzymes
|
|
US5589171A
(en)
|
1994-08-22 |
1996-12-31 |
Advance Biofactures Of Curacao |
Treatment of Dupuytren's disease with collagenase
|
|
US5496284A
(en)
|
1994-09-27 |
1996-03-05 |
Waldenburg; Ottfried |
Dual-chamber syringe & method
|
|
US5824784A
(en)
|
1994-10-12 |
1998-10-20 |
Amgen Inc. |
N-terminally chemically modified protein compositions and methods
|
|
US6544767B1
(en)
*
|
1994-10-27 |
2003-04-08 |
Axys Pharmaceuticals, Inc. |
Cathespin O2 protease
|
|
DE4445969C1
(de)
|
1994-12-22 |
1996-03-14 |
Schott Glaswerke |
Spritzenzylinder für eine Zweikammer-Fertigspritze, Zweikammer-Fertigspritze und Verfahren zum Herstellen und Füllen derselben
|
|
US5932462A
(en)
|
1995-01-10 |
1999-08-03 |
Shearwater Polymers, Inc. |
Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
|
|
US5523090A
(en)
|
1995-02-24 |
1996-06-04 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Skin treatment composition
|
|
US5536499A
(en)
|
1995-02-24 |
1996-07-16 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Cosmetic compositions for reducing or preventing signs of cellulite
|
|
US5747027A
(en)
|
1995-04-07 |
1998-05-05 |
The Regents Of The University Of California |
BH55 hyaluronidase
|
|
US6430446B1
(en)
|
1995-05-05 |
2002-08-06 |
Thermage, Inc. |
Apparatus for tissue remodeling
|
|
US5705364A
(en)
|
1995-06-06 |
1998-01-06 |
Genentech, Inc. |
Mammalian cell culture process
|
|
US5672662A
(en)
|
1995-07-07 |
1997-09-30 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
|
|
US5705170A
(en)
|
1995-10-24 |
1998-01-06 |
Plantech International, Inc. |
Herbal cellulite treatments
|
|
US5747322A
(en)
|
1996-05-09 |
1998-05-05 |
The Regents Of The University Of California |
Recombinant crab collagenase
|
|
US5976556A
(en)
|
1996-06-13 |
1999-11-02 |
Active Organics, Inc. |
Combination of acid protease enzymes and acidic buffers and uses thereof
|
|
US5667793A
(en)
|
1996-08-02 |
1997-09-16 |
Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. |
Skin care compositions for treating cellulite
|
|
US6432401B2
(en)
|
2000-05-12 |
2002-08-13 |
Novalar Pharmaceuticals, Inc. |
Local anesthetic methods and kits
|
|
US6214966B1
(en)
|
1996-09-26 |
2001-04-10 |
Shearwater Corporation |
Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
|
|
US5776759A
(en)
|
1996-09-26 |
1998-07-07 |
Incyte Pharmaceuticals, Inc. |
Two novel human cathepsin proteins
|
|
US6193963B1
(en)
|
1996-10-17 |
2001-02-27 |
The Regents Of The University Of California |
Method of treating tumor-bearing patients with human plasma hyaluronidase
|
|
US6258351B1
(en)
|
1996-11-06 |
2001-07-10 |
Shearwater Corporation |
Delivery of poly(ethylene glycol)-modified molecules from degradable hydrogels
|
|
US5830741A
(en)
|
1996-12-06 |
1998-11-03 |
Boehringer Mannheim Corporation |
Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
|
|
US6086872A
(en)
|
1997-03-27 |
2000-07-11 |
Advance Biofactures Of Curacao, Nv |
Amelioration of dupuytren's disease
|
|
US6071526A
(en)
|
1997-03-27 |
2000-06-06 |
S.W. Patentverwertungs Ges M.B. H. |
Cosmetic or cosmetic product for firming and soothing the skin in particular in the case of cellulite
|
|
US5990237A
(en)
|
1997-05-21 |
1999-11-23 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
|
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
|
AU8513198A
(en)
|
1997-07-25 |
1999-02-16 |
Du Pont Pharmaceuticals Company |
Aggrecan degrading metallo proteases
|
|
FR2767833B1
(fr)
|
1997-08-29 |
2001-03-02 |
Oreal |
Polypeptide isole de l'epiderme et son utilisation
|
|
US5971953A
(en)
|
1998-01-09 |
1999-10-26 |
Bachynsky; Nicholas |
Dual chamber syringe apparatus
|
|
US6448369B1
(en)
|
1997-11-06 |
2002-09-10 |
Shearwater Corporation |
Heterobifunctional poly(ethylene glycol) derivatives and methods for their preparation
|
|
US5985263A
(en)
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
|
US6153207A
(en)
|
1998-03-05 |
2000-11-28 |
Pugliese; Peter T. |
Anti-cellulite pantyhose
|
|
CA2323048C
(en)
|
1998-03-12 |
2006-10-10 |
Shearwater Polymers, Inc. |
Poly(ethylene glycol) derivatives with proximal reactive groups
|
|
JP2002506801A
(ja)
|
1998-03-16 |
2002-03-05 |
ザ、プロクター、エンド、ギャンブル、カンパニー |
哺乳類の皮膚のセルライトを軽減する方法
|
|
US6528286B1
(en)
|
1998-05-29 |
2003-03-04 |
Genentech, Inc. |
Mammalian cell culture process for producing glycoproteins
|
|
WO2000002017A2
(en)
|
1998-07-03 |
2000-01-13 |
Neles Field Controls Oy |
Method and arrangement for measuring fluid
|
|
US6031005A
(en)
|
1998-08-03 |
2000-02-29 |
Easterling; W. Jerry |
Composition and method for treating Peyronie's disease and related connective tissue disorders
|
|
US6443914B1
(en)
|
1998-08-10 |
2002-09-03 |
Lysonix, Inc. |
Apparatus and method for preventing and treating cellulite
|
|
US6420339B1
(en)
|
1998-10-14 |
2002-07-16 |
Amgen Inc. |
Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
|
|
US6060474A
(en)
|
1998-11-05 |
2000-05-09 |
New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery |
Method for preventing scar tissue formation
|
|
WO2000044390A1
(en)
|
1999-02-01 |
2000-08-03 |
John Lezdey |
Treatment of bladder and gastrointestinal mastocytosis
|
|
CA2370504A1
(en)
*
|
1999-04-29 |
2000-11-09 |
Ista Pharmaceuticals, Inc. |
Biochemical methods that eliminate corneal scars, opacification and haze
|
|
US6022539A
(en)
|
1999-06-03 |
2000-02-08 |
Advance Biofactures Of Curacao |
Amelioration of peyronie's disease
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
PE20010288A1
(es)
|
1999-07-02 |
2001-03-07 |
Hoffmann La Roche |
Derivados de eritropoyetina
|
|
US6656701B2
(en)
|
1999-07-16 |
2003-12-02 |
Actim Organics, Inc |
Combination of acid protease enzymes and acidic buffers and uses thereof
|
|
US6461802B1
(en)
|
1999-08-02 |
2002-10-08 |
Agfa-Gevaert |
Adhesive layer for polyester film
|
|
EP1207840B1
(en)
|
1999-08-20 |
2004-10-13 |
Howard Murad |
Pharmaceutical compositions and methods for reducing the appearance of cellulite
|
|
ITMI991894A1
(it)
|
1999-09-09 |
2001-03-09 |
Carlo Ghisalberti |
Acido linoleico coniugato e trigliceride nuovi metodi di sintesi e d'uso
|
|
US6355243B1
(en)
|
1999-11-13 |
2002-03-12 |
Bayer Corporation |
Method of thrombolysis by local delivery of active plasmin
|
|
CA2394980C
(en)
|
1999-12-22 |
2008-05-13 |
Shearwater Corporation |
Sterically hindered derivatives of water soluble polymers
|
|
US6413507B1
(en)
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
|
EP1251895A1
(en)
|
1999-12-28 |
2002-10-30 |
Easyringe ApS |
Dual chamber syringe with a dual function piston
|
|
US20030212021A1
(en)
|
2001-01-25 |
2003-11-13 |
Frost Gregory I. |
Myeloid colony stimulating factor and uses thereof
|
|
JP2003534834A
(ja)
|
2000-01-28 |
2003-11-25 |
ノボ ノルディスク アクティーゼルスカブ |
投与量設定リミッター
|
|
US6602498B2
(en)
|
2000-02-22 |
2003-08-05 |
Shearwater Corporation |
N-maleimidyl polymer derivatives
|
|
EP1261722A2
(en)
*
|
2000-02-28 |
2002-12-04 |
Millennium Pharmaceuticals, Inc. |
18036, a novel calpain-like protease and uses thereof
|
|
US6586398B1
(en)
|
2000-04-07 |
2003-07-01 |
Amgen, Inc. |
Chemically modified novel erythropoietin stimulating protein compositions and methods
|
|
NZ522847A
(en)
|
2000-05-16 |
2004-11-26 |
Bolder Biotechnology Inc |
Methods for refolding proteins containing free cysteine residues
|
|
US20020106388A1
(en)
|
2000-11-24 |
2002-08-08 |
Pugliese Peter T. |
Formulation of flavones and isoflavones for treatment of cellulite
|
|
EP1345628B1
(en)
|
2000-12-20 |
2011-04-13 |
F. Hoffmann-La Roche AG |
Conjugates of erythropoietin (epo) with polyethylene glycol (peg)
|
|
TWI246524B
(en)
|
2001-01-19 |
2006-01-01 |
Shearwater Corp |
Multi-arm block copolymers as drug delivery vehicles
|
|
US20040146494A1
(en)
*
|
2001-04-06 |
2004-07-29 |
Santana Cristiano Alberto Ribeiro |
Papaine containing pharmaceutical formulation resp its use
|
|
CA2349506C
(en)
|
2001-06-14 |
2009-12-08 |
Duke University |
A method for selective expression of therapeutic genes by hyperthermia
|
|
US20030026794A1
(en)
*
|
2001-07-31 |
2003-02-06 |
Howard Fein |
Selective enzyme treatment of skin conditions
|
|
US6908963B2
(en)
|
2001-10-09 |
2005-06-21 |
Nektar Therapeutics Al, Corporation |
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
|
|
EP1446438A2
(en)
|
2001-11-07 |
2004-08-18 |
Nektar Therapeutics Al, Corporation |
Branched polymers and their conjugates
|
|
US6972005B2
(en)
|
2002-05-10 |
2005-12-06 |
Boehm Jr Frank H |
Dual chamber syringe and dual lumen needle
|
|
US6682904B1
(en)
|
2002-08-15 |
2004-01-27 |
Deliatroph Pharmaceuticals, Inc. |
Specific inhibitors of hyaluronidase 2, and methods of identifying and using same
|
|
KR20040040782A
(ko)
|
2002-11-08 |
2004-05-13 |
선바이오(주) |
신규한 헥사-암 폴리에틸렌글리콜과 유도체 및 그의합성방법
|
|
US7544499B2
(en)
|
2002-12-16 |
2009-06-09 |
Halozyme, Inc. |
Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof
|
|
EP1596887B1
(en)
|
2003-02-26 |
2022-03-23 |
Nektar Therapeutics |
Polymer-factor viii moiety conjugates
|
|
EP2330213A1
(en)
|
2003-03-05 |
2011-06-08 |
Halozyme, Inc. |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
|
|
US20090123367A1
(en)
|
2003-03-05 |
2009-05-14 |
Delfmems |
Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases
|
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
|
US20060104968A1
(en)
*
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
|
US7610156B2
(en)
|
2003-03-31 |
2009-10-27 |
Xencor, Inc. |
Methods for rational pegylation of proteins
|
|
KR100512483B1
(ko)
|
2003-05-07 |
2005-09-05 |
선바이오(주) |
신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법
|
|
PT2644206T
(pt)
|
2003-05-23 |
2019-07-10 |
Nektar Therapeutics |
Derivados de peg contendo duas cadeias de peg
|
|
EP1654380A4
(en)
|
2003-08-14 |
2009-09-09 |
Insight Biopharmaceuticals Ltd |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING HEPARANASE ACTIVATION AND USES THEREOF
|
|
US7572613B2
(en)
|
2004-06-25 |
2009-08-11 |
Klein Jeffrey A |
Drug delivery system for accelerated subcutaneous absorption
|
|
US7854929B2
(en)
|
2005-01-21 |
2010-12-21 |
The Research Foundation Of State University Of New York |
Method for treating lateral epicondylitis using collagenase
|
|
US20070224184A1
(en)
|
2006-02-22 |
2007-09-27 |
The Research Foundation Of The State University Of New York |
Method for treating cellulite
|
|
US8143453B2
(en)
|
2005-02-25 |
2012-03-27 |
Temple University—Of the Commonwealth System of Higher Education |
Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
|
|
WO2007006030A2
(en)
|
2005-06-30 |
2007-01-11 |
Mallinckrodt Inc. |
Dual chamber syringe
|
|
US20070128685A1
(en)
|
2005-07-01 |
2007-06-07 |
Rodolfo Faudoa |
Methods and compositions for cell culture
|
|
US20070003541A1
(en)
|
2005-07-01 |
2007-01-04 |
Rodolfo Faudoa |
Methods and compositions for therapeutics
|
|
US20070004036A1
(en)
|
2005-07-01 |
2007-01-04 |
Rodolfo Faudoa |
Methods and compositions for keratinocyte culture
|
|
US7811560B2
(en)
|
2006-01-30 |
2010-10-12 |
Auxilium Us Holdings, Llc |
Compositions and methods for treating collagen-mediated diseases
|
|
US20080131500A1
(en)
|
2006-12-04 |
2008-06-05 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions for rapid inactivation of proteins
|
|
TWI395593B
(zh)
|
2008-03-06 |
2013-05-11 |
Halozyme Inc |
可活化的基質降解酵素之活體內暫時性控制
|
|
CN101970650B
(zh)
|
2008-03-06 |
2017-07-25 |
哈洛齐梅公司 |
可溶性透明质酸酶的大规模生产
|
|
WO2009128917A2
(en)
|
2008-04-14 |
2009-10-22 |
Halozyme, Inc. |
Modified hyaluronidases and uses in treating hyaluronan-associated diseases and conditions
|
|
CN102307993B
(zh)
|
2008-12-09 |
2014-06-25 |
哈洛齐梅公司 |
延长的可溶性ph20多肽及其用途
|
|
JP5649589B2
(ja)
|
2009-03-06 |
2015-01-07 |
ハロザイム インコーポレイテッド |
マトリックスメタロプロテアーゼ1の温度感受性突然変異体およびその使用
|
|
MX355507B
(es)
|
2009-03-09 |
2018-04-19 |
Bioatla Llc |
Proteinas mirac.
|
|
KR20130096731A
(ko)
|
2010-09-08 |
2013-08-30 |
할로자임, 아이엔씨 |
조건부 활성 치료적 단백질을 평가,확인 또는 진화시키는 방법
|
|
CA2866612C
(en)
|
2012-03-08 |
2018-01-16 |
Halozyme, Inc. |
Conditionally active ph-dependent cetuximab variant anti-epidermal growth factor receptor antibodies and method of use thereof
|